Recovery & performance research, explained

The question underneath "recovery" is usually specific: a slow-healing tendon, a nagging joint, a gut that reacts to training, or simply wanting to understand what athletes are talking about. Most of the research people cite is preclinical, and that is the honest starting point.

This pathway covers the peptides most often discussed in soft-tissue, gastrointestinal and mitochondrial-energy research. It does not cover training, nutrition or sleep, which move recovery far more than anything on this page.

BPC-157 has an extensive animal literature in tendon, ligament and gastric-mucosa models and very limited published human data. TB-500 (thymosin beta-4 fragment) is discussed in wound-healing research, again largely preclinical. MOTS-c and SS-31 are studied for mitochondrial function; SS-31 (elamipretide) has reached human trials for specific mitochondrial diseases, which is a different question from performance.

None of these is FDA-approved for recovery or performance, and several are prohibited in tested sport. If you compete under anti-doping rules, that alone answers the question.

The intake asks about injuries, surgeries, medications and any competitive sport. A licensed provider reviews it and tells you plainly whether a conversation about this pathway makes sense. It is free, takes about 10 minutes, and carries no obligation.